BIOTECH TARGET N V Insider Trading
Get the latest insider transactions of BIOTECH TARGET N V. BIOTECH TARGET N V is 10% Owner in Monogram Biosciences, Inc. ($VLGC) and 10% Owner in Molecular Templates, Inc. ($MTEM) and 10% Owner in MACROGENICS INC ($MGNX) and 10% Owner in Radius Health, Inc. ($RDUS) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in Cidara Therapeutics, Inc. ($CDTX). Discover the current value of BIOTECH TARGET N V shares.
Address: DE RUYTERKADE 62 WILLEMSTAD CURACO 000000P8
BIOTECH TARGET N V is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| VLGC | Monogram Biosciences, Inc. | 10% Owner | 2,001,074 | 0.00 |
| CDTX | Cidara Therapeutics, Inc. | 10% Owner | 2,295,272 | 22,034,611.20 |
| ESPR | Esperion Therapeutics, Inc. | 10% Owner | 4,097,964 | 72,370,044.24 |
| RDUS | Radius Health, Inc. | 10% Owner | 7,355,714 | 307,910,188.04 |
| MTEM | Molecular Templates, Inc. | 10% Owner | 9,542,621 | 5,820,998.81 |
| MGNX | MACROGENICS INC | 10% Owner | 6,275,564 | 116,913,757.32 |
Insider Trading Transactions of BIOTECH TARGET N V
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% Owner | Buy | 21.74 | 75,000 | 1,630,170 | 6,275,564 |
| Jun 17 2021 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% Owner | Buy | 20.53 | 75,000 | 1,539,615 | 6,100,564 |
| Jun 17 2021 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% Owner | Buy | 21.04 | 100,000 | 2,104,390 | 6,200,564 |
| May 07 2021 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 20.02 | 150,000 | 3,002,850 | 4,097,964 |
| May 07 2021 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 20.57 | 80,000 | 1,645,632 | 4,177,964 |
| Apr 21 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.08 | 40,852 | 329,941 | 9,542,621 |
| Apr 19 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.62 | 150,000 | 1,292,655 | 9,501,769 |
| Apr 15 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 7.81 | 100,000 | 780,970 | 9,201,769 |
| Apr 15 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.37 | 150,000 | 1,256,040 | 9,351,769 |
| Apr 13 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.23 | 235,664 | 1,939,633 | 9,051,769 |
| Apr 13 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.02 | 50,000 | 400,830 | 9,101,769 |
| Apr 09 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.24 | 200,000 | 1,648,160 | 8,516,105 |
| Apr 09 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.22 | 300,000 | 2,466,660 | 8,816,105 |
| Apr 07 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 9.44 | 200,000 | 1,887,100 | 8,316,105 |
| Mar 31 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 11.45 | 80,000 | 915,848 | 8,116,105 |
| Feb 25 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 11.29 | 235,004 | 2,653,031 | 7,961,105 |
| Feb 25 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 11.48 | 75,000 | 860,835 | 8,036,105 |
| Feb 19 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 12.65 | 1,185,770 | 14,999,991 | 7,726,101 |
| Feb 01 2021 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 11.94 | 80,000 | 955,000 | 6,460,331 |
| Dec 11 2020 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.62 | 125,000 | 1,077,600 | 6,060,331 |
| Dec 11 2020 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.39 | 150,000 | 1,258,425 | 6,210,331 |
| Dec 11 2020 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.18 | 170,000 | 1,391,416 | 6,380,331 |
| Nov 12 2020 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 9.05 | 80,000 | 724,144 | 5,855,331 |
| Nov 12 2020 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 9.16 | 80,000 | 732,472 | 5,935,331 |
| Nov 04 2020 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 9.40 | 80,000 | 751,688 | 5,149,996 |
| Nov 04 2020 | MTEM | Molecular Templates, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 8.83 | 80,000 | 706,312 | 5,229,996 |
| Nov 04 2020 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 25.31 | 200,000 | 5,062,120 | 3,947,964 |
| Sep 16 2020 | RDUS | Radius Health, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 11.69 | 200,000 | 2,338,680 | 7,355,714 |
| Sep 14 2020 | RDUS | Radius Health, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 11.33 | 199,029 | 2,255,118 | 7,155,714 |
| Jul 09 2020 | RDUS | Radius Health, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 13.21 | 25,000 | 330,178 | 6,956,685 |
| May 04 2020 | RDUS | Radius Health, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 15.75 | 50,000 | 787,555 | 6,931,685 |
| Jan 27 2020 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 52.12 | 20,000 | 1,042,398 | 3,747,964 |
| Nov 08 2019 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 37.30 | 75,000 | 2,797,560 | 3,727,964 |
| Sep 06 2019 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 33.78 | 80,000 | 2,702,208 | 3,652,964 |
| Jul 25 2019 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 42.65 | 50,000 | 2,132,565 | 3,572,964 |
| Mar 15 2019 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 49.89 | 50,000 | 2,494,355 | 3,522,964 |
| Jan 07 2019 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 41.29 | 80,000 | 3,303,256 | 3,472,964 |
| Dec 26 2018 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 39.91 | 50,000 | 1,995,725 | 3,392,964 |
| Dec 19 2018 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 47.73 | 60,000 | 2,864,070 | 3,342,964 |
| Aug 06 2018 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 46.14 | 50,000 | 2,306,970 | 3,282,964 |
| Jul 13 2018 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 41.77 | 50,000 | 2,088,300 | 3,232,964 |
| Jul 03 2018 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 39.48 | 50,000 | 1,973,805 | 3,182,964 |
| Jun 25 2018 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 38.57 | 60,000 | 2,314,224 | 3,132,964 |
| Jun 11 2018 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 37.79 | 60,000 | 2,267,292 | 3,072,964 |
| Jun 07 2018 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 38.47 | 60,000 | 2,308,440 | 3,012,964 |
| May 22 2018 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 42.24 | 50,000 | 2,112,010 | 2,872,964 |
| May 22 2018 | ESPR | Esperion Therapeutics, In ... | BIOTECH TARGET N V | 10% Owner | Buy | 38.77 | 80,000 | 3,101,760 | 2,952,964 |
| Nov 16 2017 | CDTX | Cidara Therapeutics, Inc. | BIOTECH TARGET N V | 10% Owner | Buy | 7.57 | 60,000 | 453,966 | 2,295,272 |
| Dec 31 2003 | VLGC | Monogram Biosciences, Inc ... | BIOTECH TARGET N V | 10% Owner | Buy | 1.21 | 2,001,074 | 2,421,300 | 2,001,074 |
| Dec 31 2003 | VLGC | Monogram Biosciences, Inc ... | BIOTECH TARGET N V | 10% Owner | Option Exercise | 0.00 | 242 | 0 | 0 |